IDEXX Laboratories Inc

詳細情報 IDEXX Laboratories Inc 企業名

IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services primarily for the companion animal veterinary, livestock and poultry, dairy and water testing industries. The Company also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. Its Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. Its LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, to improve the quality and safety of milk.

企業情報

企業コードIDXX

会社名IDEXX Laboratories Inc

上場日Jun 21, 1991

最高経営責任者「CEO」Mr. Andrew Emerson

従業員数11000

証券種類Ordinary Share

決算期末Jun 21

本社所在地One Idexx Drive

都市WESTBROOK

証券取引所NASDAQ Global Select Consolidated

国United States of America

郵便番号04092-2041

電話番号12075560300

ウェブサイトhttps://www.idexx.com/

企業コードIDXX

上場日Jun 21, 1991

最高経営責任者「CEO」Mr. Andrew Emerson

役員一覧

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Michael Erickson, Ph.D.

Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine

12.58K

+18.05%

Dr. Sophie V. Vandebroek, Ph.D.

Independent Director

8.69K

+3.11%

Mr. Lawrence D. (Larry) Kingsley

Independent Chairman of the Board

8.23K

+4.39%

Mr. Michael J. Lane

Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology

7.70K

--

Ms. Sharon E. Underberg

Executive Vice President, General Counsel, Corporate Secretary

6.12K

+3.08%

Mr. Andrew Emerson

Executive Vice President, Chief Executive Officer, Treasurer

3.84K

+60.39%

Mr. Daniel M. (Dan) Junius

Independent Director

3.00K

+9.56%

Mr. Michael Schreck

Executive Vice President and General Manager, Veterinary Software and Services, Corporate Accounts and Customer Experience

1.92K

+112.86%

Mr. Bruce L. Claflin

Independent Director

1.72K

--

Dr. Stuart M. Essig, Ph.D.

Independent Director

1.09K

+31.76%

詳細を見る

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Michael Erickson, Ph.D.

Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine

12.58K

+18.05%

Dr. Sophie V. Vandebroek, Ph.D.

Independent Director

8.69K

+3.11%

Mr. Lawrence D. (Larry) Kingsley

Independent Chairman of the Board

8.23K

+4.39%

Mr. Michael J. Lane

Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology

7.70K

--

Ms. Sharon E. Underberg

Executive Vice President, General Counsel, Corporate Secretary

6.12K

+3.08%

Mr. Andrew Emerson

Executive Vice President, Chief Executive Officer, Treasurer

3.84K

+60.39%

収益内訳

通貨: USD更新時刻: Sun, Jul 6

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

事業別USD

会社名

収益

比率

CAG Diagnostics recurring revenue

806.27M

80.75%

IDEXX VetLab consumables

344.78M

34.53%

Reference laboratory diagnostic and consulting services

344.41M

34.49%

Rapid assay products

84.03M

8.42%

Veterinary software, services and diagnostic imaging systems

81.58M

8.17%

他の

-662.63M

-66.37%

地域別USD

会社名

収益

比率

United States

654.86M

65.59%

Europe & Middle East & Africa (EMEA) (Region)

204.55M

20.49%

Asia Pacific

81.73M

8.19%

Canada

37.30M

3.74%

Latin America

19.99M

2.00%

事業別

地域別

事業別USD

会社名

収益

比率

CAG Diagnostics recurring revenue

806.27M

80.75%

IDEXX VetLab consumables

344.78M

34.53%

Reference laboratory diagnostic and consulting services

344.41M

34.49%

Rapid assay products

84.03M

8.42%

Veterinary software, services and diagnostic imaging systems

81.58M

8.17%

他の

-662.63M

-66.37%

株主

更新時刻: Tue, Aug 19

株主統計

種類

株主統計

比率

The Vanguard Group, Inc.

12.30%

BlackRock Institutional Trust Company, N.A.

6.63%

State Street Global Advisors (US)

4.44%

Fundsmith LLP

3.30%

Geode Capital Management, L.L.C.

3.08%

他の

70.25%

株主統計

比率

The Vanguard Group, Inc.

12.30%

BlackRock Institutional Trust Company, N.A.

6.63%

State Street Global Advisors (US)

4.44%

Fundsmith LLP

3.30%

Geode Capital Management, L.L.C.

3.08%

他の

70.25%

種類

株主統計

比率

Investment Advisor

54.34%

Investment Advisor/Hedge Fund

32.78%

Research Firm

3.95%

Pension Fund

2.29%

Bank and Trust

2.06%

Hedge Fund

0.93%

Individual Investor

0.69%

Sovereign Wealth Fund

0.61%

Family Office

0.54%

他の

1.82%

機関投資家保有株

更新時刻: Tue, Jul 1

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q2

2277

79.81M

99.73%

-1.01M

2025Q1

2279

79.02M

98.21%

-512.23K

2024Q4

2242

76.14M

93.59%

-5.30M

2024Q3

2152

77.90M

94.66%

-4.67M

2024Q2

2140

80.09M

96.98%

-924.14K

2024Q1

2154

77.56M

93.40%

-2.57M

2023Q4

2187

77.94M

93.84%

-2.83M

2023Q3

2153

79.23M

95.34%

-677.16K

2023Q2

2157

77.53M

93.40%

-1.56M

2023Q1

2158

77.14M

92.96%

-2.07M

詳細を見る

株主動向

会社名

保有株式数

比率

変動額

変動率

日付

The Vanguard Group, Inc.

9.82M

12.21%

+146.37K

+1.51%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

5.44M

6.76%

+113.70K

+2.14%

Mar 31, 2025

State Street Global Advisors (US)

3.65M

4.54%

+12.32K

+0.34%

Mar 31, 2025

Fundsmith LLP

2.65M

3.29%

-14.52K

-0.55%

Mar 31, 2025

Geode Capital Management, L.L.C.

2.41M

3%

+112.62K

+4.90%

Mar 31, 2025

Baron Capital Management, Inc.

2.06M

2.56%

+54.26K

+2.71%

Mar 31, 2025

Invesco Capital Management (QQQ Trust)

1.66M

2.07%

-25.31K

-1.50%

Jun 30, 2025

Principal Global Investors (Equity)

1.13M

1.4%

+414.80K

+58.32%

Mar 31, 2025

William Blair & Company, L.L.C. (Research)

1.09M

1.36%

-14.24K

-1.29%

Mar 31, 2025

詳細を見る

632.220USD

IDEXX Laboratories Inc

632.220

概要

企業名

金融

分析